30.87MMarket Cap-497P/E (TTM)
1.2000High1.1100Low150.30KVolume1.1800Open1.2200Pre Close174.93KTurnover0.66%Turnover RatioLossP/E (Static)27.32MShares3.550052wk High-1.17P/B25.59MFloat Cap1.050952wk Low--Dividend TTM22.65MShs Float143.4487Historical High--Div YieldTTM7.38%Amplitude1.0500Historical Low1.1630Avg Price1Lot Size
Trinity Biotech Stock Forum
Trinity Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(22.6%),Perceptive Credit Advisors LLC(22.6%), etc.
📊⚡️📊
Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform
No comment yet